Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity

Full-length VAR2CSA is a potential placental malaria vaccine candidate and in this study, Renn et al. compare antigenicity and receptor binding affinity of different allelic variants in blood samples from pregnant women. Their data show that inter-allelic differences may contribute to the heterogene...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jonathan P. Renn, Justin Y. A. Doritchamou, Bergeline C. Nguemwo Tentokam, Robert D. Morrison, Matthew V. Cowles, Martin Burkhardt, Rui Ma, Niraj H. Tolia, Michal Fried, Patrick E. Duffy
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/9468370d9ab9416c980d5d735228618e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9468370d9ab9416c980d5d735228618e
record_format dspace
spelling oai:doaj.org-article:9468370d9ab9416c980d5d735228618e2021-11-21T12:08:21ZAllelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity10.1038/s42003-021-02787-72399-3642https://doaj.org/article/9468370d9ab9416c980d5d735228618e2021-11-01T00:00:00Zhttps://doi.org/10.1038/s42003-021-02787-7https://doaj.org/toc/2399-3642Full-length VAR2CSA is a potential placental malaria vaccine candidate and in this study, Renn et al. compare antigenicity and receptor binding affinity of different allelic variants in blood samples from pregnant women. Their data show that inter-allelic differences may contribute to the heterogeneity of clinical presentations, which could have implications for vaccine design.Jonathan P. RennJustin Y. A. DoritchamouBergeline C. Nguemwo TentokamRobert D. MorrisonMatthew V. CowlesMartin BurkhardtRui MaNiraj H. ToliaMichal FriedPatrick E. DuffyNature PortfolioarticleBiology (General)QH301-705.5ENCommunications Biology, Vol 4, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Jonathan P. Renn
Justin Y. A. Doritchamou
Bergeline C. Nguemwo Tentokam
Robert D. Morrison
Matthew V. Cowles
Martin Burkhardt
Rui Ma
Niraj H. Tolia
Michal Fried
Patrick E. Duffy
Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity
description Full-length VAR2CSA is a potential placental malaria vaccine candidate and in this study, Renn et al. compare antigenicity and receptor binding affinity of different allelic variants in blood samples from pregnant women. Their data show that inter-allelic differences may contribute to the heterogeneity of clinical presentations, which could have implications for vaccine design.
format article
author Jonathan P. Renn
Justin Y. A. Doritchamou
Bergeline C. Nguemwo Tentokam
Robert D. Morrison
Matthew V. Cowles
Martin Burkhardt
Rui Ma
Niraj H. Tolia
Michal Fried
Patrick E. Duffy
author_facet Jonathan P. Renn
Justin Y. A. Doritchamou
Bergeline C. Nguemwo Tentokam
Robert D. Morrison
Matthew V. Cowles
Martin Burkhardt
Rui Ma
Niraj H. Tolia
Michal Fried
Patrick E. Duffy
author_sort Jonathan P. Renn
title Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity
title_short Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity
title_full Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity
title_fullStr Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity
title_full_unstemmed Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity
title_sort allelic variants of full-length var2csa, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/9468370d9ab9416c980d5d735228618e
work_keys_str_mv AT jonathanprenn allelicvariantsoffulllengthvar2csatheplacentalmalariavaccinecandidatedifferinantigenicityandreceptorbindingaffinity
AT justinyadoritchamou allelicvariantsoffulllengthvar2csatheplacentalmalariavaccinecandidatedifferinantigenicityandreceptorbindingaffinity
AT bergelinecnguemwotentokam allelicvariantsoffulllengthvar2csatheplacentalmalariavaccinecandidatedifferinantigenicityandreceptorbindingaffinity
AT robertdmorrison allelicvariantsoffulllengthvar2csatheplacentalmalariavaccinecandidatedifferinantigenicityandreceptorbindingaffinity
AT matthewvcowles allelicvariantsoffulllengthvar2csatheplacentalmalariavaccinecandidatedifferinantigenicityandreceptorbindingaffinity
AT martinburkhardt allelicvariantsoffulllengthvar2csatheplacentalmalariavaccinecandidatedifferinantigenicityandreceptorbindingaffinity
AT ruima allelicvariantsoffulllengthvar2csatheplacentalmalariavaccinecandidatedifferinantigenicityandreceptorbindingaffinity
AT nirajhtolia allelicvariantsoffulllengthvar2csatheplacentalmalariavaccinecandidatedifferinantigenicityandreceptorbindingaffinity
AT michalfried allelicvariantsoffulllengthvar2csatheplacentalmalariavaccinecandidatedifferinantigenicityandreceptorbindingaffinity
AT patrickeduffy allelicvariantsoffulllengthvar2csatheplacentalmalariavaccinecandidatedifferinantigenicityandreceptorbindingaffinity
_version_ 1718419200065667072